124 related articles for article (PubMed ID: 18481986)
1. Substances that can change alternative splice-site selection.
Sumanasekera C; Watt DS; Stamm S
Biochem Soc Trans; 2008 Jun; 36(Pt 3):483-90. PubMed ID: 18481986
[TBL] [Abstract][Full Text] [Related]
2. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
3. How did alternative splicing evolve?
Ast G
Nat Rev Genet; 2004 Oct; 5(10):773-82. PubMed ID: 15510168
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing interference by xenobiotics.
Zaharieva E; Chipman JK; Soller M
Toxicology; 2012 Jun; 296(1-3):1-12. PubMed ID: 22321775
[TBL] [Abstract][Full Text] [Related]
5. The usage of alternative splice sites in Mus musculus synaptotagmin-like 2 gene is modulated by cyclosporin A and FK506 in T-lymphocytes.
Mascarell L; Auger R; Kanellopoulos JM; Truffa-Bachi P
Mol Immunol; 2006 Apr; 43(11):1846-54. PubMed ID: 16376427
[TBL] [Abstract][Full Text] [Related]
6. Single amino-acid InDel variants generated by alternative tandem splice-donor and -acceptor selection.
Lai CH; Hu LY; Lin WC
Biochem Biophys Res Commun; 2006 Mar; 342(1):197-205. PubMed ID: 16472775
[TBL] [Abstract][Full Text] [Related]
7. Does distance matter? Variations in alternative 3' splicing regulation.
Akerman M; Mandel-Gutfreund Y
Nucleic Acids Res; 2007; 35(16):5487-98. PubMed ID: 17704130
[TBL] [Abstract][Full Text] [Related]
8. Function of alternative splicing.
Stamm S; Ben-Ari S; Rafalska I; Tang Y; Zhang Z; Toiber D; Thanaraj TA; Soreq H
Gene; 2005 Jan; 344():1-20. PubMed ID: 15656968
[TBL] [Abstract][Full Text] [Related]
9. Activation-induced changes in alternate splice acceptor site usage.
Atkinson TP; Dai Y
Biochem Biophys Res Commun; 2007 Jun; 358(2):590-5. PubMed ID: 17498651
[TBL] [Abstract][Full Text] [Related]
10. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
Mourich DV; Iversen PL
Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
[TBL] [Abstract][Full Text] [Related]
11. The effect of U1 snRNA binding free energy on the selection of 5' splice sites.
Bi J; Xia H; Li F; Zhang X; Li Y
Biochem Biophys Res Commun; 2005 Jul; 333(1):64-9. PubMed ID: 15936716
[TBL] [Abstract][Full Text] [Related]
12. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations that influence pre-mRNA splicing.
Zhang Z; Stamm S
Methods Mol Biol; 2011; 703():137-60. PubMed ID: 21125488
[TBL] [Abstract][Full Text] [Related]
14. Widespread and subtle: alternative splicing at short-distance tandem sites.
Hiller M; Platzer M
Trends Genet; 2008 May; 24(5):246-55. PubMed ID: 18394746
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing produces a constitutively active form of human SREBP-1.
Harada N; Yonemoto H; Yoshida M; Yamamoto H; Yin Y; Miyamoto A; Hattori A; Wu Q; Nakagawa T; Nakano M; Teshigawara K; Mawatari K; Hosaka T; Takahashi A; Nakaya Y
Biochem Biophys Res Commun; 2008 Apr; 368(3):820-6. PubMed ID: 18267114
[TBL] [Abstract][Full Text] [Related]
16. The emergence of alternative 3' and 5' splice site exons from constitutive exons.
Koren E; Lev-Maor G; Ast G
PLoS Comput Biol; 2007 May; 3(5):e95. PubMed ID: 17530917
[TBL] [Abstract][Full Text] [Related]
17. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
18. Using estimative reaction free energy to predict splice sites and their flanking competitors.
Jin HY; Luo LF; Zhang LR
Gene; 2008 Nov; 424(1-2):115-20. PubMed ID: 18761064
[TBL] [Abstract][Full Text] [Related]
19. Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.
Hobson GM; Huang Z; Sperle K; Sistermans E; Rogan PK; Garbern JY; Kolodny E; Naidu S; Cambi F
Hum Mutat; 2006 Jan; 27(1):69-77. PubMed ID: 16287154
[TBL] [Abstract][Full Text] [Related]
20. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
